Global Covered Esophageal Stent Market Growth 2026-2032
The global Covered Esophageal Stent market size is predicted to grow from US$ 295 million in 2025 to US$ 468 million in 2032; it is expected to grow at a CAGR of 6.8% from 2026 to 2032.
Covered Esophageal Stent refers to a covered endoluminal implant designed to restore esophageal patency, prevent tissue ingrowth or seal defects in the esophageal wall. The market is dominated by self-expanding metal stents manufactured from braided nitinol wire or laser-cut nitinol tubing and covered with silicone, polyurethane, expanded polytetrafluoroethylene or comparable medical polymers. Products are supplied preloaded in endoscopic or fluoroscopic delivery systems and are principally classified as fully covered and partially covered esophageal stents. Functional designs may incorporate flared ends, anti-migration struts, retrieval sutures, anti-reflux valves, double-layer meshes or specialized cervical configurations. Key specifications include stent body and flange diameter, covered and overall length, delivery-system profile, radial and axial force, shortening ratio, conformability, radiopacity, covering integrity, migration resistance, repositionability and removability. Principal applications include malignant esophageal strictures and dysphagia, refractory benign esophageal strictures, esophagorespiratory fistulas, postoperative leaks and esophageal perforations.
Key Findings
In 2025, global Covered Esophageal Stent production reached approximately 193 K Units, with an average global market price of around US$ 1,565 per unit.
Covered nitinol SEMS constitute the principal product platform within the target market
Fully covered products support sealing and retrieval but require stronger migration control
Malignant esophageal stricture remains the most established clinical application
Benign strictures, fistulas and perforations support temporary removable stent demand
Competition combines multinational platforms with specialized Korean, European and Chinese manufacturers
Market Trends
The market is evolving from general-purpose covered tubular stents toward indication-specific systems optimized for lesion location, esophageal anatomy and treatment duration. Manufacturers are seeking to provide sufficient radial force to open severe strictures while reducing axial force, flange stiffness and pressure on healthy tissue. Fully covered designs increasingly incorporate flared ends, anchoring fins, anti-migration struts, collars, double-layer meshes and proximal or distal retrieval sutures to combine stable fixation with safe removal. Lower-profile and through-the-scope delivery systems improve access through tight or tortuous stenoses and can enable deployment under direct endoscopic visualization. Specialized products are expanding, including soft-ended devices for cervical or proximal lesions, anti-reflux models for stents crossing the gastroesophageal junction, large-diameter configurations for postoperative leaks and perforations, and emergency stents for refractory esophageal variceal bleeding. Reduced foreshortening, controlled release, partial recapture and immediate repositioning are becoming important procurement criteria. Hospitals increasingly evaluate the complete clinical pathway, including placement accuracy, dwell-time management, migration monitoring, retrieval technique and adverse-event support, rather than assessing nominal stent specifications alone.
Market Dynamics
Drivers
Demand is principally driven by esophageal cancer and other malignancies that cause dysphagia through intrinsic tumor growth or external compression. Covered stents can rapidly restore oral intake, reduce tumor ingrowth and support palliative care, nutritional recovery and subsequent oncology treatment. Population aging and wider access to therapeutic endoscopy expand the eligible patient population. Advances in endoscopic imaging, fluoroscopic navigation, guidewires and delivery systems also allow physicians to manage tighter and more anatomically complex lesions. Refractory benign esophageal strictures create demand for temporary removable stents when repeated dilation has not provided durable relief. Clinical use is further supported by the role of fully covered products in sealing esophagorespiratory fistulas, postoperative anastomotic leaks and selected spontaneous or iatrogenic perforations. Multidisciplinary collaboration among gastroenterologists, thoracic surgeons, oncologists and interventional radiologists improves patient selection and facilitates standardized treatment pathways.
Restraints
Market adoption is constrained by stent migration, chest pain, gastroesophageal reflux, food impaction, bleeding, tissue overgrowth, recurrent dysphagia and perforation. Fully covered stents prevent tissue ingrowth and facilitate retrieval, but reduced integration with the esophageal wall can increase migration risk. Partially covered products achieve stronger anchoring through uncovered portions, although tissue embedding may complicate later removal. Clinical outcomes vary according to lesion position, stricture length, proximity to the upper esophageal sphincter or gastroesophageal junction, previous radiotherapy, stent diameter and operator experience. Balloon dilation, surgery, feeding-access procedures and other endoscopic therapies remain alternatives for selected patients. Commercialization is also affected by regional differences in indications, reimbursement and hospital procurement. Benign applications require strict dwell-time control, retrieval planning and follow-up, which limits use in institutions without experienced therapeutic-endoscopy teams.
Opportunities
Temporary management of refractory benign strictures, postoperative anastomotic leaks, esophageal fistulas and perforations represents a major opportunity for fully covered and reliably removable stents. Products combining low migration, atraumatic retrieval and predictable force distribution can broaden physician acceptance. Proximal and cervical lesions create demand for small-diameter, soft-ended devices, while distal lesions crossing the gastroesophageal junction support anti-reflux configurations. Through-the-scope systems offer potential in severe and tortuous stenoses by reducing delivery profile and enabling direct visualization. Large-diameter, high-sealing-force products can address postoperative leaks and spontaneous or iatrogenic ruptures. Specialized covered stents for temporary control of refractory esophageal variceal bleeding constitute a smaller but clinically differentiated segment. Emerging markets provide additional growth potential as cancer diagnosis and therapeutic-endoscopy capacity improve. Manufacturers can create value through indication-specific sizes, standardized placement and retrieval protocols, physician training, procedural accessories, local case support and prospective clinical evidence.
Challenges
The core engineering challenge is balancing radial expansion, axial flexibility, migration resistance and atraumatic contact with the esophageal wall. Excessive radial force may increase pain or pressure-related injury, while insufficient force can compromise patency or defect sealing. Aggressive anchoring structures may reduce migration but increase mucosal trauma or retrieval difficulty. Covering materials must withstand gastric acid exposure, food abrasion and repeated esophageal movement without tearing, delamination or loss of elasticity. Deployment accuracy can be affected by foreshortening, elongation, severe stenosis and delivery-catheter resistance. Clinical evidence is difficult to compare because malignant strictures, benign disease, fistulas and perforations have different treatment objectives, dwell times and follow-up periods. Manufacturers must maintain consistent nitinol properties, mesh geometry, membrane thickness, marker location, sterilization and delivery-system reliability. Design modifications or expanded indications can also trigger additional regulatory and clinical-validation requirements.
Industry Chain Analysis
The upstream chain comprises medical-grade nitinol wire or tubing, silicone, polyurethane and expanded polytetrafluoroethylene coverings, platinum-iridium or tantalum radiopaque markers, retrieval sutures, polymer catheters, guidewire-compatible components, sterilization services and precision manufacturing equipment. Production processes include wire braiding or laser cutting, heat setting, electropolishing, cleaning, membrane application, flange and anti-migration structure formation, marker assembly, delivery-system integration, packaging and sterilization validation. Midstream value is created through stent geometry, radial and axial force engineering, covering durability, migration control, deployment accuracy, repositioning or retrieval capability and batch consistency. Finished systems reach hospitals through direct sales organizations, endoscopy-platform companies and specialized distributors. Downstream users include gastroenterology departments, cancer centers, thoracic surgery units and interventional radiology teams. Commercial value extends beyond implant production to regulatory registration, clinical evidence, physician education, procedure support, inventory availability, traceability and post-market surveillance. Reliable retrieval devices and standardized management protocols are particularly important for temporary fully covered stents.
Segment Insights
By covering structure, fully covered and partially covered esophageal stents constitute the primary classification. Fully covered products use a polymer membrane across the entire stent body and generally over both ends, preventing tumor or granulation-tissue ingrowth and facilitating removal. Migration is their principal design limitation, leading manufacturers to incorporate flared ends, anchoring fins, anti-migration struts, collars, double-layer structures and retrieval sutures. Partially covered products retain uncovered sections, usually at one or both ends, to strengthen anchoring while using a covered central body to reduce tumor ingrowth. They are widely associated with malignant dysphagia but may become embedded when tissue grows through the uncovered mesh, increasing removal complexity.
Additional commercially relevant classifications include braided-wire versus laser-cut construction, silicone versus other polymer coverings, proximal versus distal release, over-the-wire versus through-the-scope deployment, and removable versus long-term palliative use. Functional variants include conventional, anti-reflux, cervical, low-radial-force, high-sealing-force and variceal-bleeding stents. By application, the initial structure of malignant esophageal stricture, benign esophageal stricture, esophageal fistula and perforation, and other indications is appropriate. The other category mainly covers postoperative anastomotic leakage, refractory esophageal variceal bleeding and specialized esophageal complications rather than unrelated gastrointestinal diseases.
Downstream Market Opportunities
Malignant esophageal stricture is the most established application because covered stents can restore swallowing and reduce tumor ingrowth in patients requiring palliation. Benign esophageal strictures constitute a selective market centered on refractory cases in which repeated dilation has failed and scheduled stent removal is feasible. Esophagorespiratory fistulas require dependable sealing to reduce aspiration, while postoperative anastomotic leaks and esophageal perforations demand sufficient covered length, membrane durability and positional stability. Stents crossing the gastroesophageal junction can benefit from anti-reflux valves, whereas cervical strictures require softer proximal ends and carefully selected diameters. Refractory esophageal variceal bleeding represents a specialized emergency application rather than a conventional stricture market. Suppliers offering indication-specific dimensions, retrieval systems, clinical protocols and physician training can access higher-value demand than manufacturers supplying undifferentiated covered stents.
Regional Insights
North America and Europe are mature markets with established oncology pathways, therapeutic-endoscopy infrastructure and stringent regulatory requirements. Boston Scientific, Cook Medical and Merit Medical Systems have broad commercial platforms and hospital access, while ELLA-CS, ENDO-FLEX, Leufen Medical and AndraTec provide specialized European products. Innovation focuses on removable fully covered systems, lower-profile delivery devices, migration prevention and evidence-supported management of benign strictures, fistulas and perforations. Approved indications differ between the United States, Europe and other jurisdictions, making regulatory portfolio management a significant competitive factor.
South Korea is an important specialist manufacturing base represented by M.I.Tech, Taewoong Medical and Sewoon Medical. Their portfolios cover diverse esophageal geometries, covering configurations, release systems and anti-reflux functions. Japan has a sophisticated endoscopy market and strong distribution capabilities; Olympus supplies selected HANAROSTENT esophageal products manufactured by M.I.Tech and should therefore be treated as a product provider and distributor rather than the independent manufacturing source of those devices. China is expanding through Micro-Tech Endoscopy, Jiangsu Vedkang, Changzhou Zhiye Medical Instrument Research Institute and Anrei Medical. T?rkiye, India and other emerging production regions participate through INVAMED, Mitra Industries and additional regional suppliers, subject to product-level registration and current manufacturing verification.
Competitive Landscape Analysis
The market comprises multinational endoscopy companies, specialist covered-stent manufacturers and regional product providers. Boston Scientific supplies fully and partially covered WallFlex esophageal stents and competes through portfolio breadth, delivery-system control and international hospital access. Cook Medical offers the Evolution controlled-release platform, while Merit Medical Systems focuses on fully covered laser-cut products such as EndoMAXX and ALIMAXX-ES, emphasizing deployment accuracy, retrieval and anti-migration characteristics. M.I.Tech manufactures the HANAROSTENT esophageal line distributed by Olympus in the United States, meaning the two companies should not be counted as separate manufacturers for the relevant products. Taewoong Medical is an important omission from the initial list and should be added to the core enterprise pool; its Niti-S portfolio includes fully covered, double-layer, cervical and anti-reflux esophageal configurations. ELLA-CS differentiates through removable fully covered products, leak-sealing systems and the Danis stent for refractory variceal bleeding. Micro-Tech Endoscopy, ENDO-FLEX, Leufen Medical, Sewoon Medical, INVAMED, Jiangsu Vedkang, Changzhou Zhiye, Anrei Medical, AndraTec and Mitra Industries form the extended specialist pool. Competitive differentiation centers on force balance, migration control, membrane integrity, delivery profile, retrieval performance, regulatory coverage and physician support, and supplier rankings should not be inferred without comparable audited sales data.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Covered Esophageal Stent Industry Forecast” looks at past sales and reviews total world Covered Esophageal Stent sales in 2025, providing a comprehensive analysis by region and market sector of projected Covered Esophageal Stent sales for 2026 through 2032. With Covered Esophageal Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Covered Esophageal Stent industry.
This Insight Report provides a comprehensive analysis of the global Covered Esophageal Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Covered Esophageal Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Covered Esophageal Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Covered Esophageal Stent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Covered Esophageal Stent.
This report presents a comprehensive overview, market shares, and growth opportunities of Covered Esophageal Stent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Covered Esophageal Stent refers to a covered endoluminal implant designed to restore esophageal patency, prevent tissue ingrowth or seal defects in the esophageal wall. The market is dominated by self-expanding metal stents manufactured from braided nitinol wire or laser-cut nitinol tubing and covered with silicone, polyurethane, expanded polytetrafluoroethylene or comparable medical polymers. Products are supplied preloaded in endoscopic or fluoroscopic delivery systems and are principally classified as fully covered and partially covered esophageal stents. Functional designs may incorporate flared ends, anti-migration struts, retrieval sutures, anti-reflux valves, double-layer meshes or specialized cervical configurations. Key specifications include stent body and flange diameter, covered and overall length, delivery-system profile, radial and axial force, shortening ratio, conformability, radiopacity, covering integrity, migration resistance, repositionability and removability. Principal applications include malignant esophageal strictures and dysphagia, refractory benign esophageal strictures, esophagorespiratory fistulas, postoperative leaks and esophageal perforations.
Key Findings
In 2025, global Covered Esophageal Stent production reached approximately 193 K Units, with an average global market price of around US$ 1,565 per unit.
Covered nitinol SEMS constitute the principal product platform within the target market
Fully covered products support sealing and retrieval but require stronger migration control
Malignant esophageal stricture remains the most established clinical application
Benign strictures, fistulas and perforations support temporary removable stent demand
Competition combines multinational platforms with specialized Korean, European and Chinese manufacturers
Market Trends
The market is evolving from general-purpose covered tubular stents toward indication-specific systems optimized for lesion location, esophageal anatomy and treatment duration. Manufacturers are seeking to provide sufficient radial force to open severe strictures while reducing axial force, flange stiffness and pressure on healthy tissue. Fully covered designs increasingly incorporate flared ends, anchoring fins, anti-migration struts, collars, double-layer meshes and proximal or distal retrieval sutures to combine stable fixation with safe removal. Lower-profile and through-the-scope delivery systems improve access through tight or tortuous stenoses and can enable deployment under direct endoscopic visualization. Specialized products are expanding, including soft-ended devices for cervical or proximal lesions, anti-reflux models for stents crossing the gastroesophageal junction, large-diameter configurations for postoperative leaks and perforations, and emergency stents for refractory esophageal variceal bleeding. Reduced foreshortening, controlled release, partial recapture and immediate repositioning are becoming important procurement criteria. Hospitals increasingly evaluate the complete clinical pathway, including placement accuracy, dwell-time management, migration monitoring, retrieval technique and adverse-event support, rather than assessing nominal stent specifications alone.
Market Dynamics
Drivers
Demand is principally driven by esophageal cancer and other malignancies that cause dysphagia through intrinsic tumor growth or external compression. Covered stents can rapidly restore oral intake, reduce tumor ingrowth and support palliative care, nutritional recovery and subsequent oncology treatment. Population aging and wider access to therapeutic endoscopy expand the eligible patient population. Advances in endoscopic imaging, fluoroscopic navigation, guidewires and delivery systems also allow physicians to manage tighter and more anatomically complex lesions. Refractory benign esophageal strictures create demand for temporary removable stents when repeated dilation has not provided durable relief. Clinical use is further supported by the role of fully covered products in sealing esophagorespiratory fistulas, postoperative anastomotic leaks and selected spontaneous or iatrogenic perforations. Multidisciplinary collaboration among gastroenterologists, thoracic surgeons, oncologists and interventional radiologists improves patient selection and facilitates standardized treatment pathways.
Restraints
Market adoption is constrained by stent migration, chest pain, gastroesophageal reflux, food impaction, bleeding, tissue overgrowth, recurrent dysphagia and perforation. Fully covered stents prevent tissue ingrowth and facilitate retrieval, but reduced integration with the esophageal wall can increase migration risk. Partially covered products achieve stronger anchoring through uncovered portions, although tissue embedding may complicate later removal. Clinical outcomes vary according to lesion position, stricture length, proximity to the upper esophageal sphincter or gastroesophageal junction, previous radiotherapy, stent diameter and operator experience. Balloon dilation, surgery, feeding-access procedures and other endoscopic therapies remain alternatives for selected patients. Commercialization is also affected by regional differences in indications, reimbursement and hospital procurement. Benign applications require strict dwell-time control, retrieval planning and follow-up, which limits use in institutions without experienced therapeutic-endoscopy teams.
Opportunities
Temporary management of refractory benign strictures, postoperative anastomotic leaks, esophageal fistulas and perforations represents a major opportunity for fully covered and reliably removable stents. Products combining low migration, atraumatic retrieval and predictable force distribution can broaden physician acceptance. Proximal and cervical lesions create demand for small-diameter, soft-ended devices, while distal lesions crossing the gastroesophageal junction support anti-reflux configurations. Through-the-scope systems offer potential in severe and tortuous stenoses by reducing delivery profile and enabling direct visualization. Large-diameter, high-sealing-force products can address postoperative leaks and spontaneous or iatrogenic ruptures. Specialized covered stents for temporary control of refractory esophageal variceal bleeding constitute a smaller but clinically differentiated segment. Emerging markets provide additional growth potential as cancer diagnosis and therapeutic-endoscopy capacity improve. Manufacturers can create value through indication-specific sizes, standardized placement and retrieval protocols, physician training, procedural accessories, local case support and prospective clinical evidence.
Challenges
The core engineering challenge is balancing radial expansion, axial flexibility, migration resistance and atraumatic contact with the esophageal wall. Excessive radial force may increase pain or pressure-related injury, while insufficient force can compromise patency or defect sealing. Aggressive anchoring structures may reduce migration but increase mucosal trauma or retrieval difficulty. Covering materials must withstand gastric acid exposure, food abrasion and repeated esophageal movement without tearing, delamination or loss of elasticity. Deployment accuracy can be affected by foreshortening, elongation, severe stenosis and delivery-catheter resistance. Clinical evidence is difficult to compare because malignant strictures, benign disease, fistulas and perforations have different treatment objectives, dwell times and follow-up periods. Manufacturers must maintain consistent nitinol properties, mesh geometry, membrane thickness, marker location, sterilization and delivery-system reliability. Design modifications or expanded indications can also trigger additional regulatory and clinical-validation requirements.
Industry Chain Analysis
The upstream chain comprises medical-grade nitinol wire or tubing, silicone, polyurethane and expanded polytetrafluoroethylene coverings, platinum-iridium or tantalum radiopaque markers, retrieval sutures, polymer catheters, guidewire-compatible components, sterilization services and precision manufacturing equipment. Production processes include wire braiding or laser cutting, heat setting, electropolishing, cleaning, membrane application, flange and anti-migration structure formation, marker assembly, delivery-system integration, packaging and sterilization validation. Midstream value is created through stent geometry, radial and axial force engineering, covering durability, migration control, deployment accuracy, repositioning or retrieval capability and batch consistency. Finished systems reach hospitals through direct sales organizations, endoscopy-platform companies and specialized distributors. Downstream users include gastroenterology departments, cancer centers, thoracic surgery units and interventional radiology teams. Commercial value extends beyond implant production to regulatory registration, clinical evidence, physician education, procedure support, inventory availability, traceability and post-market surveillance. Reliable retrieval devices and standardized management protocols are particularly important for temporary fully covered stents.
Segment Insights
By covering structure, fully covered and partially covered esophageal stents constitute the primary classification. Fully covered products use a polymer membrane across the entire stent body and generally over both ends, preventing tumor or granulation-tissue ingrowth and facilitating removal. Migration is their principal design limitation, leading manufacturers to incorporate flared ends, anchoring fins, anti-migration struts, collars, double-layer structures and retrieval sutures. Partially covered products retain uncovered sections, usually at one or both ends, to strengthen anchoring while using a covered central body to reduce tumor ingrowth. They are widely associated with malignant dysphagia but may become embedded when tissue grows through the uncovered mesh, increasing removal complexity.
Additional commercially relevant classifications include braided-wire versus laser-cut construction, silicone versus other polymer coverings, proximal versus distal release, over-the-wire versus through-the-scope deployment, and removable versus long-term palliative use. Functional variants include conventional, anti-reflux, cervical, low-radial-force, high-sealing-force and variceal-bleeding stents. By application, the initial structure of malignant esophageal stricture, benign esophageal stricture, esophageal fistula and perforation, and other indications is appropriate. The other category mainly covers postoperative anastomotic leakage, refractory esophageal variceal bleeding and specialized esophageal complications rather than unrelated gastrointestinal diseases.
Downstream Market Opportunities
Malignant esophageal stricture is the most established application because covered stents can restore swallowing and reduce tumor ingrowth in patients requiring palliation. Benign esophageal strictures constitute a selective market centered on refractory cases in which repeated dilation has failed and scheduled stent removal is feasible. Esophagorespiratory fistulas require dependable sealing to reduce aspiration, while postoperative anastomotic leaks and esophageal perforations demand sufficient covered length, membrane durability and positional stability. Stents crossing the gastroesophageal junction can benefit from anti-reflux valves, whereas cervical strictures require softer proximal ends and carefully selected diameters. Refractory esophageal variceal bleeding represents a specialized emergency application rather than a conventional stricture market. Suppliers offering indication-specific dimensions, retrieval systems, clinical protocols and physician training can access higher-value demand than manufacturers supplying undifferentiated covered stents.
Regional Insights
North America and Europe are mature markets with established oncology pathways, therapeutic-endoscopy infrastructure and stringent regulatory requirements. Boston Scientific, Cook Medical and Merit Medical Systems have broad commercial platforms and hospital access, while ELLA-CS, ENDO-FLEX, Leufen Medical and AndraTec provide specialized European products. Innovation focuses on removable fully covered systems, lower-profile delivery devices, migration prevention and evidence-supported management of benign strictures, fistulas and perforations. Approved indications differ between the United States, Europe and other jurisdictions, making regulatory portfolio management a significant competitive factor.
South Korea is an important specialist manufacturing base represented by M.I.Tech, Taewoong Medical and Sewoon Medical. Their portfolios cover diverse esophageal geometries, covering configurations, release systems and anti-reflux functions. Japan has a sophisticated endoscopy market and strong distribution capabilities; Olympus supplies selected HANAROSTENT esophageal products manufactured by M.I.Tech and should therefore be treated as a product provider and distributor rather than the independent manufacturing source of those devices. China is expanding through Micro-Tech Endoscopy, Jiangsu Vedkang, Changzhou Zhiye Medical Instrument Research Institute and Anrei Medical. T?rkiye, India and other emerging production regions participate through INVAMED, Mitra Industries and additional regional suppliers, subject to product-level registration and current manufacturing verification.
Competitive Landscape Analysis
The market comprises multinational endoscopy companies, specialist covered-stent manufacturers and regional product providers. Boston Scientific supplies fully and partially covered WallFlex esophageal stents and competes through portfolio breadth, delivery-system control and international hospital access. Cook Medical offers the Evolution controlled-release platform, while Merit Medical Systems focuses on fully covered laser-cut products such as EndoMAXX and ALIMAXX-ES, emphasizing deployment accuracy, retrieval and anti-migration characteristics. M.I.Tech manufactures the HANAROSTENT esophageal line distributed by Olympus in the United States, meaning the two companies should not be counted as separate manufacturers for the relevant products. Taewoong Medical is an important omission from the initial list and should be added to the core enterprise pool; its Niti-S portfolio includes fully covered, double-layer, cervical and anti-reflux esophageal configurations. ELLA-CS differentiates through removable fully covered products, leak-sealing systems and the Danis stent for refractory variceal bleeding. Micro-Tech Endoscopy, ENDO-FLEX, Leufen Medical, Sewoon Medical, INVAMED, Jiangsu Vedkang, Changzhou Zhiye, Anrei Medical, AndraTec and Mitra Industries form the extended specialist pool. Competitive differentiation centers on force balance, migration control, membrane integrity, delivery profile, retrieval performance, regulatory coverage and physician support, and supplier rankings should not be inferred without comparable audited sales data.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Covered Esophageal Stent Industry Forecast” looks at past sales and reviews total world Covered Esophageal Stent sales in 2025, providing a comprehensive analysis by region and market sector of projected Covered Esophageal Stent sales for 2026 through 2032. With Covered Esophageal Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Covered Esophageal Stent industry.
This Insight Report provides a comprehensive analysis of the global Covered Esophageal Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Covered Esophageal Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Covered Esophageal Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Covered Esophageal Stent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Covered Esophageal Stent.
This report presents a comprehensive overview, market shares, and growth opportunities of Covered Esophageal Stent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Fully Covered Esophageal Stent
- Partially Covered Esophageal Stent
Segmentation by External Structure:
- Double Cup Mouth Cylindrical Mesh
- Cup Mouth Ball Head Cylindrical Mesh
Segmentation by Diameter:
- Diameter 16 mm
- Diameter 18 mm
- Diameter 20 mm
- Diameter 22 mm
- Diameter 25 mm
Segmentation by Application:
- Malignant Esophageal Stricture
- Benign Esophageal Stricture
- Esophageal Fistula and Perforation
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boston Scientific
- Cook Medical
- M.I.Tech
- Merit Medical Systems
- Olympus Corporation
- ELLA-CS, s.r.o.
- ENDO-FLEX GmbH
- Leufen Medical
- Micro-Tech Endoscopy
- Anrei medical (hz)
- Mitra Industries Private Limited
- Sewoon Medical
- INVAMED
- Jiangsu Vedkang Medical Science and Technology
- Changzhou Zhiye Medical Instrument Research Institute
- AndraTec
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Covered Esophageal Stent market?
- What factors are driving Covered Esophageal Stent market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Covered Esophageal Stent market opportunities vary by end market size?
- How does Covered Esophageal Stent break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Covered Esophageal Stent Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Covered Esophageal Stent by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Covered Esophageal Stent by Country/Region, 2021, 2025 & 2032
2.2 Covered Esophageal Stent Segment by Type
2.2.1 Fully Covered Esophageal Stent
2.2.2 Partially Covered Esophageal Stent
2.2.3 Covered Esophageal Stent Sales by Type
2.2.3.1 Global Covered Esophageal Stent Sales Market Share by Type (2021-2026)
2.2.3.2 Global Covered Esophageal Stent Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Covered Esophageal Stent Sale Price by Type (2021-2026)
2.3 Covered Esophageal Stent Segment by External Structure
2.3.1 Double Cup Mouth Cylindrical Mesh
2.3.2 Cup Mouth Ball Head Cylindrical Mesh
2.3.3 Covered Esophageal Stent Sales by External Structure
2.3.3.1 Global Covered Esophageal Stent Sales Market Share by External Structure (2021-2026)
2.3.3.2 Global Covered Esophageal Stent Revenue and Market Share by External Structure (2021-2026)
2.3.3.3 Global Covered Esophageal Stent Sale Price by External Structure (2021-2026)
2.4 Covered Esophageal Stent Segment by Diameter
2.4.1 Diameter 16 mm
2.4.2 Diameter 18 mm
2.4.3 Diameter 20 mm
2.4.4 Diameter 22 mm
2.4.5 Diameter 25 mm
2.4.6 Covered Esophageal Stent Sales by Diameter
2.4.6.1 Global Covered Esophageal Stent Sales Market Share by Diameter (2021-2026)
2.4.6.2 Global Covered Esophageal Stent Revenue and Market Share by Diameter (2021-2026)
2.4.6.3 Global Covered Esophageal Stent Sale Price by Diameter (2021-2026)
2.5 Covered Esophageal Stent Segment by Application
2.5.1 Malignant Esophageal Stricture
2.5.2 Benign Esophageal Stricture
2.5.3 Esophageal Fistula and Perforation
2.5.4 Other
2.5.5 Covered Esophageal Stent Sales by Application
2.5.5.1 Global Covered Esophageal Stent Sale Market Share by Application (2021-2026)
2.5.5.2 Global Covered Esophageal Stent Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Covered Esophageal Stent Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Covered Esophageal Stent Breakdown Data by Company
3.1.1 Global Covered Esophageal Stent Annual Sales by Company (2021-2026)
3.1.2 Global Covered Esophageal Stent Sales Market Share by Company (2021-2026)
3.2 Global Covered Esophageal Stent Annual Revenue by Company (2021-2026)
3.2.1 Global Covered Esophageal Stent Revenue by Company (2021-2026)
3.2.2 Global Covered Esophageal Stent Revenue Market Share by Company (2021-2026)
3.3 Global Covered Esophageal Stent Sale Price by Company
3.4 Key Manufacturers Covered Esophageal Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Covered Esophageal Stent Product Location Distribution
3.4.2 Players Covered Esophageal Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR COVERED ESOPHAGEAL STENT BY GEOGRAPHIC REGION
4.1 World Historic Covered Esophageal Stent Market Size by Geographic Region (2021-2026)
4.1.1 Global Covered Esophageal Stent Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Covered Esophageal Stent Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Covered Esophageal Stent Market Size by Country/Region (2021-2026)
4.2.1 Global Covered Esophageal Stent Annual Sales by Country/Region (2021-2026)
4.2.2 Global Covered Esophageal Stent Annual Revenue by Country/Region (2021-2026)
4.3 Americas Covered Esophageal Stent Sales Growth
4.4 APAC Covered Esophageal Stent Sales Growth
4.5 Europe Covered Esophageal Stent Sales Growth
4.6 Middle East & Africa Covered Esophageal Stent Sales Growth
5 AMERICAS
5.1 Americas Covered Esophageal Stent Sales by Country
5.1.1 Americas Covered Esophageal Stent Sales by Country (2021-2026)
5.1.2 Americas Covered Esophageal Stent Revenue by Country (2021-2026)
5.2 Americas Covered Esophageal Stent Sales by Type (2021-2026)
5.3 Americas Covered Esophageal Stent Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Covered Esophageal Stent Sales by Region
6.1.1 APAC Covered Esophageal Stent Sales by Region (2021-2026)
6.1.2 APAC Covered Esophageal Stent Revenue by Region (2021-2026)
6.2 APAC Covered Esophageal Stent Sales by Type (2021-2026)
6.3 APAC Covered Esophageal Stent Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Covered Esophageal Stent by Country
7.1.1 Europe Covered Esophageal Stent Sales by Country (2021-2026)
7.1.2 Europe Covered Esophageal Stent Revenue by Country (2021-2026)
7.2 Europe Covered Esophageal Stent Sales by Type (2021-2026)
7.3 Europe Covered Esophageal Stent Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Covered Esophageal Stent by Country
8.1.1 Middle East & Africa Covered Esophageal Stent Sales by Country (2021-2026)
8.1.2 Middle East & Africa Covered Esophageal Stent Revenue by Country (2021-2026)
8.2 Middle East & Africa Covered Esophageal Stent Sales by Type (2021-2026)
8.3 Middle East & Africa Covered Esophageal Stent Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Covered Esophageal Stent
10.3 Manufacturing Process Analysis of Covered Esophageal Stent
10.4 Industry Chain Structure of Covered Esophageal Stent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Covered Esophageal Stent Distributors
11.3 Covered Esophageal Stent Customer
12 WORLD FORECAST REVIEW FOR COVERED ESOPHAGEAL STENT BY GEOGRAPHIC REGION
12.1 Global Covered Esophageal Stent Market Size Forecast by Region
12.1.1 Global Covered Esophageal Stent Forecast by Region (2027-2032)
12.1.2 Global Covered Esophageal Stent Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Covered Esophageal Stent Forecast by Type (2027-2032)
12.7 Global Covered Esophageal Stent Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Covered Esophageal Stent Product Portfolios and Specifications
13.1.3 Boston Scientific Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Cook Medical
13.2.1 Cook Medical Company Information
13.2.2 Cook Medical Covered Esophageal Stent Product Portfolios and Specifications
13.2.3 Cook Medical Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Cook Medical Main Business Overview
13.2.5 Cook Medical Latest Developments
13.3 M.I.Tech
13.3.1 M.I.Tech Company Information
13.3.2 M.I.Tech Covered Esophageal Stent Product Portfolios and Specifications
13.3.3 M.I.Tech Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 M.I.Tech Main Business Overview
13.3.5 M.I.Tech Latest Developments
13.4 Merit Medical Systems
13.4.1 Merit Medical Systems Company Information
13.4.2 Merit Medical Systems Covered Esophageal Stent Product Portfolios and Specifications
13.4.3 Merit Medical Systems Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merit Medical Systems Main Business Overview
13.4.5 Merit Medical Systems Latest Developments
13.5 Olympus Corporation
13.5.1 Olympus Corporation Company Information
13.5.2 Olympus Corporation Covered Esophageal Stent Product Portfolios and Specifications
13.5.3 Olympus Corporation Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Olympus Corporation Main Business Overview
13.5.5 Olympus Corporation Latest Developments
13.6 ELLA-CS, s.r.o.
13.6.1 ELLA-CS, s.r.o. Company Information
13.6.2 ELLA-CS, s.r.o. Covered Esophageal Stent Product Portfolios and Specifications
13.6.3 ELLA-CS, s.r.o. Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 ELLA-CS, s.r.o. Main Business Overview
13.6.5 ELLA-CS, s.r.o. Latest Developments
13.7 ENDO-FLEX GmbH
13.7.1 ENDO-FLEX GmbH Company Information
13.7.2 ENDO-FLEX GmbH Covered Esophageal Stent Product Portfolios and Specifications
13.7.3 ENDO-FLEX GmbH Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ENDO-FLEX GmbH Main Business Overview
13.7.5 ENDO-FLEX GmbH Latest Developments
13.8 Leufen Medical
13.8.1 Leufen Medical Company Information
13.8.2 Leufen Medical Covered Esophageal Stent Product Portfolios and Specifications
13.8.3 Leufen Medical Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Leufen Medical Main Business Overview
13.8.5 Leufen Medical Latest Developments
13.9 Micro-Tech Endoscopy
13.9.1 Micro-Tech Endoscopy Company Information
13.9.2 Micro-Tech Endoscopy Covered Esophageal Stent Product Portfolios and Specifications
13.9.3 Micro-Tech Endoscopy Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Micro-Tech Endoscopy Main Business Overview
13.9.5 Micro-Tech Endoscopy Latest Developments
13.10 Anrei medical (hz)
13.10.1 Anrei medical (hz) Company Information
13.10.2 Anrei medical (hz) Covered Esophageal Stent Product Portfolios and Specifications
13.10.3 Anrei medical (hz) Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Anrei medical (hz) Main Business Overview
13.10.5 Anrei medical (hz) Latest Developments
13.11 Mitra Industries Private Limited
13.11.1 Mitra Industries Private Limited Company Information
13.11.2 Mitra Industries Private Limited Covered Esophageal Stent Product Portfolios and Specifications
13.11.3 Mitra Industries Private Limited Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Mitra Industries Private Limited Main Business Overview
13.11.5 Mitra Industries Private Limited Latest Developments
13.12 Sewoon Medical
13.12.1 Sewoon Medical Company Information
13.12.2 Sewoon Medical Covered Esophageal Stent Product Portfolios and Specifications
13.12.3 Sewoon Medical Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Sewoon Medical Main Business Overview
13.12.5 Sewoon Medical Latest Developments
13.13 INVAMED
13.13.1 INVAMED Company Information
13.13.2 INVAMED Covered Esophageal Stent Product Portfolios and Specifications
13.13.3 INVAMED Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 INVAMED Main Business Overview
13.13.5 INVAMED Latest Developments
13.14 Jiangsu Vedkang Medical Science and Technology
13.14.1 Jiangsu Vedkang Medical Science and Technology Company Information
13.14.2 Jiangsu Vedkang Medical Science and Technology Covered Esophageal Stent Product Portfolios and Specifications
13.14.3 Jiangsu Vedkang Medical Science and Technology Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Jiangsu Vedkang Medical Science and Technology Main Business Overview
13.14.5 Jiangsu Vedkang Medical Science and Technology Latest Developments
13.15 Changzhou Zhiye Medical Instrument Research Institute
13.15.1 Changzhou Zhiye Medical Instrument Research Institute Company Information
13.15.2 Changzhou Zhiye Medical Instrument Research Institute Covered Esophageal Stent Product Portfolios and Specifications
13.15.3 Changzhou Zhiye Medical Instrument Research Institute Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Changzhou Zhiye Medical Instrument Research Institute Main Business Overview
13.15.5 Changzhou Zhiye Medical Instrument Research Institute Latest Developments
13.16 AndraTec
13.16.1 AndraTec Company Information
13.16.2 AndraTec Covered Esophageal Stent Product Portfolios and Specifications
13.16.3 AndraTec Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 AndraTec Main Business Overview
13.16.5 AndraTec Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Covered Esophageal Stent Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Covered Esophageal Stent by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Covered Esophageal Stent by Country/Region, 2021, 2025 & 2032
2.2 Covered Esophageal Stent Segment by Type
2.2.1 Fully Covered Esophageal Stent
2.2.2 Partially Covered Esophageal Stent
2.2.3 Covered Esophageal Stent Sales by Type
2.2.3.1 Global Covered Esophageal Stent Sales Market Share by Type (2021-2026)
2.2.3.2 Global Covered Esophageal Stent Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Covered Esophageal Stent Sale Price by Type (2021-2026)
2.3 Covered Esophageal Stent Segment by External Structure
2.3.1 Double Cup Mouth Cylindrical Mesh
2.3.2 Cup Mouth Ball Head Cylindrical Mesh
2.3.3 Covered Esophageal Stent Sales by External Structure
2.3.3.1 Global Covered Esophageal Stent Sales Market Share by External Structure (2021-2026)
2.3.3.2 Global Covered Esophageal Stent Revenue and Market Share by External Structure (2021-2026)
2.3.3.3 Global Covered Esophageal Stent Sale Price by External Structure (2021-2026)
2.4 Covered Esophageal Stent Segment by Diameter
2.4.1 Diameter 16 mm
2.4.2 Diameter 18 mm
2.4.3 Diameter 20 mm
2.4.4 Diameter 22 mm
2.4.5 Diameter 25 mm
2.4.6 Covered Esophageal Stent Sales by Diameter
2.4.6.1 Global Covered Esophageal Stent Sales Market Share by Diameter (2021-2026)
2.4.6.2 Global Covered Esophageal Stent Revenue and Market Share by Diameter (2021-2026)
2.4.6.3 Global Covered Esophageal Stent Sale Price by Diameter (2021-2026)
2.5 Covered Esophageal Stent Segment by Application
2.5.1 Malignant Esophageal Stricture
2.5.2 Benign Esophageal Stricture
2.5.3 Esophageal Fistula and Perforation
2.5.4 Other
2.5.5 Covered Esophageal Stent Sales by Application
2.5.5.1 Global Covered Esophageal Stent Sale Market Share by Application (2021-2026)
2.5.5.2 Global Covered Esophageal Stent Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Covered Esophageal Stent Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Covered Esophageal Stent Breakdown Data by Company
3.1.1 Global Covered Esophageal Stent Annual Sales by Company (2021-2026)
3.1.2 Global Covered Esophageal Stent Sales Market Share by Company (2021-2026)
3.2 Global Covered Esophageal Stent Annual Revenue by Company (2021-2026)
3.2.1 Global Covered Esophageal Stent Revenue by Company (2021-2026)
3.2.2 Global Covered Esophageal Stent Revenue Market Share by Company (2021-2026)
3.3 Global Covered Esophageal Stent Sale Price by Company
3.4 Key Manufacturers Covered Esophageal Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Covered Esophageal Stent Product Location Distribution
3.4.2 Players Covered Esophageal Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR COVERED ESOPHAGEAL STENT BY GEOGRAPHIC REGION
4.1 World Historic Covered Esophageal Stent Market Size by Geographic Region (2021-2026)
4.1.1 Global Covered Esophageal Stent Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Covered Esophageal Stent Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Covered Esophageal Stent Market Size by Country/Region (2021-2026)
4.2.1 Global Covered Esophageal Stent Annual Sales by Country/Region (2021-2026)
4.2.2 Global Covered Esophageal Stent Annual Revenue by Country/Region (2021-2026)
4.3 Americas Covered Esophageal Stent Sales Growth
4.4 APAC Covered Esophageal Stent Sales Growth
4.5 Europe Covered Esophageal Stent Sales Growth
4.6 Middle East & Africa Covered Esophageal Stent Sales Growth
5 AMERICAS
5.1 Americas Covered Esophageal Stent Sales by Country
5.1.1 Americas Covered Esophageal Stent Sales by Country (2021-2026)
5.1.2 Americas Covered Esophageal Stent Revenue by Country (2021-2026)
5.2 Americas Covered Esophageal Stent Sales by Type (2021-2026)
5.3 Americas Covered Esophageal Stent Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Covered Esophageal Stent Sales by Region
6.1.1 APAC Covered Esophageal Stent Sales by Region (2021-2026)
6.1.2 APAC Covered Esophageal Stent Revenue by Region (2021-2026)
6.2 APAC Covered Esophageal Stent Sales by Type (2021-2026)
6.3 APAC Covered Esophageal Stent Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Covered Esophageal Stent by Country
7.1.1 Europe Covered Esophageal Stent Sales by Country (2021-2026)
7.1.2 Europe Covered Esophageal Stent Revenue by Country (2021-2026)
7.2 Europe Covered Esophageal Stent Sales by Type (2021-2026)
7.3 Europe Covered Esophageal Stent Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Covered Esophageal Stent by Country
8.1.1 Middle East & Africa Covered Esophageal Stent Sales by Country (2021-2026)
8.1.2 Middle East & Africa Covered Esophageal Stent Revenue by Country (2021-2026)
8.2 Middle East & Africa Covered Esophageal Stent Sales by Type (2021-2026)
8.3 Middle East & Africa Covered Esophageal Stent Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Covered Esophageal Stent
10.3 Manufacturing Process Analysis of Covered Esophageal Stent
10.4 Industry Chain Structure of Covered Esophageal Stent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Covered Esophageal Stent Distributors
11.3 Covered Esophageal Stent Customer
12 WORLD FORECAST REVIEW FOR COVERED ESOPHAGEAL STENT BY GEOGRAPHIC REGION
12.1 Global Covered Esophageal Stent Market Size Forecast by Region
12.1.1 Global Covered Esophageal Stent Forecast by Region (2027-2032)
12.1.2 Global Covered Esophageal Stent Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Covered Esophageal Stent Forecast by Type (2027-2032)
12.7 Global Covered Esophageal Stent Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Covered Esophageal Stent Product Portfolios and Specifications
13.1.3 Boston Scientific Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Cook Medical
13.2.1 Cook Medical Company Information
13.2.2 Cook Medical Covered Esophageal Stent Product Portfolios and Specifications
13.2.3 Cook Medical Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Cook Medical Main Business Overview
13.2.5 Cook Medical Latest Developments
13.3 M.I.Tech
13.3.1 M.I.Tech Company Information
13.3.2 M.I.Tech Covered Esophageal Stent Product Portfolios and Specifications
13.3.3 M.I.Tech Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 M.I.Tech Main Business Overview
13.3.5 M.I.Tech Latest Developments
13.4 Merit Medical Systems
13.4.1 Merit Medical Systems Company Information
13.4.2 Merit Medical Systems Covered Esophageal Stent Product Portfolios and Specifications
13.4.3 Merit Medical Systems Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Merit Medical Systems Main Business Overview
13.4.5 Merit Medical Systems Latest Developments
13.5 Olympus Corporation
13.5.1 Olympus Corporation Company Information
13.5.2 Olympus Corporation Covered Esophageal Stent Product Portfolios and Specifications
13.5.3 Olympus Corporation Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Olympus Corporation Main Business Overview
13.5.5 Olympus Corporation Latest Developments
13.6 ELLA-CS, s.r.o.
13.6.1 ELLA-CS, s.r.o. Company Information
13.6.2 ELLA-CS, s.r.o. Covered Esophageal Stent Product Portfolios and Specifications
13.6.3 ELLA-CS, s.r.o. Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 ELLA-CS, s.r.o. Main Business Overview
13.6.5 ELLA-CS, s.r.o. Latest Developments
13.7 ENDO-FLEX GmbH
13.7.1 ENDO-FLEX GmbH Company Information
13.7.2 ENDO-FLEX GmbH Covered Esophageal Stent Product Portfolios and Specifications
13.7.3 ENDO-FLEX GmbH Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ENDO-FLEX GmbH Main Business Overview
13.7.5 ENDO-FLEX GmbH Latest Developments
13.8 Leufen Medical
13.8.1 Leufen Medical Company Information
13.8.2 Leufen Medical Covered Esophageal Stent Product Portfolios and Specifications
13.8.3 Leufen Medical Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Leufen Medical Main Business Overview
13.8.5 Leufen Medical Latest Developments
13.9 Micro-Tech Endoscopy
13.9.1 Micro-Tech Endoscopy Company Information
13.9.2 Micro-Tech Endoscopy Covered Esophageal Stent Product Portfolios and Specifications
13.9.3 Micro-Tech Endoscopy Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Micro-Tech Endoscopy Main Business Overview
13.9.5 Micro-Tech Endoscopy Latest Developments
13.10 Anrei medical (hz)
13.10.1 Anrei medical (hz) Company Information
13.10.2 Anrei medical (hz) Covered Esophageal Stent Product Portfolios and Specifications
13.10.3 Anrei medical (hz) Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Anrei medical (hz) Main Business Overview
13.10.5 Anrei medical (hz) Latest Developments
13.11 Mitra Industries Private Limited
13.11.1 Mitra Industries Private Limited Company Information
13.11.2 Mitra Industries Private Limited Covered Esophageal Stent Product Portfolios and Specifications
13.11.3 Mitra Industries Private Limited Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Mitra Industries Private Limited Main Business Overview
13.11.5 Mitra Industries Private Limited Latest Developments
13.12 Sewoon Medical
13.12.1 Sewoon Medical Company Information
13.12.2 Sewoon Medical Covered Esophageal Stent Product Portfolios and Specifications
13.12.3 Sewoon Medical Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Sewoon Medical Main Business Overview
13.12.5 Sewoon Medical Latest Developments
13.13 INVAMED
13.13.1 INVAMED Company Information
13.13.2 INVAMED Covered Esophageal Stent Product Portfolios and Specifications
13.13.3 INVAMED Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 INVAMED Main Business Overview
13.13.5 INVAMED Latest Developments
13.14 Jiangsu Vedkang Medical Science and Technology
13.14.1 Jiangsu Vedkang Medical Science and Technology Company Information
13.14.2 Jiangsu Vedkang Medical Science and Technology Covered Esophageal Stent Product Portfolios and Specifications
13.14.3 Jiangsu Vedkang Medical Science and Technology Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Jiangsu Vedkang Medical Science and Technology Main Business Overview
13.14.5 Jiangsu Vedkang Medical Science and Technology Latest Developments
13.15 Changzhou Zhiye Medical Instrument Research Institute
13.15.1 Changzhou Zhiye Medical Instrument Research Institute Company Information
13.15.2 Changzhou Zhiye Medical Instrument Research Institute Covered Esophageal Stent Product Portfolios and Specifications
13.15.3 Changzhou Zhiye Medical Instrument Research Institute Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Changzhou Zhiye Medical Instrument Research Institute Main Business Overview
13.15.5 Changzhou Zhiye Medical Instrument Research Institute Latest Developments
13.16 AndraTec
13.16.1 AndraTec Company Information
13.16.2 AndraTec Covered Esophageal Stent Product Portfolios and Specifications
13.16.3 AndraTec Covered Esophageal Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 AndraTec Main Business Overview
13.16.5 AndraTec Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Covered Esophageal Stent Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Covered Esophageal Stent Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fully Covered Esophageal Stent
Table 4. Major Players of Partially Covered Esophageal Stent
Table 5. Global Covered Esophageal Stent Sales by Type (2021-2026) & (K Units)
Table 6. Global Covered Esophageal Stent Sales Market Share by Type (2021-2026)
Table 7. Global Covered Esophageal Stent Revenue by Type (2021-2026) & ($ million)
Table 8. Global Covered Esophageal Stent Revenue Market Share by Type (2021-2026)
Table 9. Global Covered Esophageal Stent Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Double Cup Mouth Cylindrical Mesh
Table 11. Major Players of Cup Mouth Ball Head Cylindrical Mesh
Table 12. Global Covered Esophageal Stent Sales by External Structure (2021-2026) & (K Units)
Table 13. Global Covered Esophageal Stent Sales Market Share by External Structure (2021-2026)
Table 14. Global Covered Esophageal Stent Revenue by External Structure (2021-2026) & ($ million)
Table 15. Global Covered Esophageal Stent Revenue Market Share by External Structure (2021-2026)
Table 16. Global Covered Esophageal Stent Sale Price by External Structure (2021-2026) & (US$/Unit)
Table 17. Major Players of Diameter 16 mm
Table 18. Major Players of Diameter 18 mm
Table 19. Major Players of Diameter 20 mm
Table 20. Major Players of Diameter 22 mm
Table 21. Major Players of Diameter 25 mm
Table 22. Global Covered Esophageal Stent Sales by Diameter (2021-2026) & (K Units)
Table 23. Global Covered Esophageal Stent Sales Market Share by Diameter (2021-2026)
Table 24. Global Covered Esophageal Stent Revenue by Diameter (2021-2026) & ($ million)
Table 25. Global Covered Esophageal Stent Revenue Market Share by Diameter (2021-2026)
Table 26. Global Covered Esophageal Stent Sale Price by Diameter (2021-2026) & (US$/Unit)
Table 27. Global Covered Esophageal Stent Sale by Application (2021-2026) & (K Units)
Table 28. Global Covered Esophageal Stent Sale Market Share by Application (2021-2026)
Table 29. Global Covered Esophageal Stent Revenue by Application (2021-2026) & ($ million)
Table 30. Global Covered Esophageal Stent Revenue Market Share by Application (2021-2026)
Table 31. Global Covered Esophageal Stent Sale Price by Application (2021-2026) & (US$/Unit)
Table 32. Global Covered Esophageal Stent Sales by Company (2021-2026) & (K Units)
Table 33. Global Covered Esophageal Stent Sales Market Share by Company (2021-2026)
Table 34. Global Covered Esophageal Stent Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Covered Esophageal Stent Revenue Market Share by Company (2021-2026)
Table 36. Global Covered Esophageal Stent Sale Price by Company (2021-2026) & (US$/Unit)
Table 37. Key Manufacturers Covered Esophageal Stent Producing Area Distribution and Sales Area
Table 38. Players Covered Esophageal Stent Products Offered
Table 39. Covered Esophageal Stent Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Covered Esophageal Stent Sales by Geographic Region (2021-2026) & (K Units)
Table 43. Global Covered Esophageal Stent Sales Market Share Geographic Region (2021-2026)
Table 44. Global Covered Esophageal Stent Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Covered Esophageal Stent Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Covered Esophageal Stent Sales by Country/Region (2021-2026) & (K Units)
Table 47. Global Covered Esophageal Stent Sales Market Share by Country/Region (2021-2026)
Table 48. Global Covered Esophageal Stent Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Covered Esophageal Stent Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Covered Esophageal Stent Sales by Country (2021-2026) & (K Units)
Table 51. Americas Covered Esophageal Stent Sales Market Share by Country (2021-2026)
Table 52. Americas Covered Esophageal Stent Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Covered Esophageal Stent Sales by Type (2021-2026) & (K Units)
Table 54. Americas Covered Esophageal Stent Sales by Application (2021-2026) & (K Units)
Table 55. APAC Covered Esophageal Stent Sales by Region (2021-2026) & (K Units)
Table 56. APAC Covered Esophageal Stent Sales Market Share by Region (2021-2026)
Table 57. APAC Covered Esophageal Stent Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Covered Esophageal Stent Sales by Type (2021-2026) & (K Units)
Table 59. APAC Covered Esophageal Stent Sales by Application (2021-2026) & (K Units)
Table 60. Europe Covered Esophageal Stent Sales by Country (2021-2026) & (K Units)
Table 61. Europe Covered Esophageal Stent Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Covered Esophageal Stent Sales by Type (2021-2026) & (K Units)
Table 63. Europe Covered Esophageal Stent Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Covered Esophageal Stent Sales by Country (2021-2026) & (K Units)
Table 65. Middle East & Africa Covered Esophageal Stent Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Covered Esophageal Stent Sales by Type (2021-2026) & (K Units)
Table 67. Middle East & Africa Covered Esophageal Stent Sales by Application (2021-2026) & (K Units)
Table 68. Key Market Drivers & Growth Opportunities of Covered Esophageal Stent
Table 69. Key Market Challenges & Risks of Covered Esophageal Stent
Table 70. Key Industry Trends of Covered Esophageal Stent
Table 71. Covered Esophageal Stent Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Covered Esophageal Stent Distributors List
Table 74. Covered Esophageal Stent Customer List
Table 75. Global Covered Esophageal Stent Sales Forecast by Region (2027-2032) & (K Units)
Table 76. Global Covered Esophageal Stent Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Covered Esophageal Stent Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Americas Covered Esophageal Stent Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Covered Esophageal Stent Sales Forecast by Region (2027-2032) & (K Units)
Table 80. APAC Covered Esophageal Stent Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Covered Esophageal Stent Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Europe Covered Esophageal Stent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Covered Esophageal Stent Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Middle East & Africa Covered Esophageal Stent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Covered Esophageal Stent Sales Forecast by Type (2027-2032) & (K Units)
Table 86. Global Covered Esophageal Stent Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Covered Esophageal Stent Sales Forecast by Application (2027-2032) & (K Units)
Table 88. Global Covered Esophageal Stent Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Boston Scientific Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 90. Boston Scientific Covered Esophageal Stent Product Portfolios and Specifications
Table 91. Boston Scientific Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Boston Scientific Main Business
Table 93. Boston Scientific Latest Developments
Table 94. Cook Medical Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 95. Cook Medical Covered Esophageal Stent Product Portfolios and Specifications
Table 96. Cook Medical Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Cook Medical Main Business
Table 98. Cook Medical Latest Developments
Table 99. M.I.Tech Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 100. M.I.Tech Covered Esophageal Stent Product Portfolios and Specifications
Table 101. M.I.Tech Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. M.I.Tech Main Business
Table 103. M.I.Tech Latest Developments
Table 104. Merit Medical Systems Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 105. Merit Medical Systems Covered Esophageal Stent Product Portfolios and Specifications
Table 106. Merit Medical Systems Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Merit Medical Systems Main Business
Table 108. Merit Medical Systems Latest Developments
Table 109. Olympus Corporation Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 110. Olympus Corporation Covered Esophageal Stent Product Portfolios and Specifications
Table 111. Olympus Corporation Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Olympus Corporation Main Business
Table 113. Olympus Corporation Latest Developments
Table 114. ELLA-CS, s.r.o. Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 115. ELLA-CS, s.r.o. Covered Esophageal Stent Product Portfolios and Specifications
Table 116. ELLA-CS, s.r.o. Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. ELLA-CS, s.r.o. Main Business
Table 118. ELLA-CS, s.r.o. Latest Developments
Table 119. ENDO-FLEX GmbH Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 120. ENDO-FLEX GmbH Covered Esophageal Stent Product Portfolios and Specifications
Table 121. ENDO-FLEX GmbH Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. ENDO-FLEX GmbH Main Business
Table 123. ENDO-FLEX GmbH Latest Developments
Table 124. Leufen Medical Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 125. Leufen Medical Covered Esophageal Stent Product Portfolios and Specifications
Table 126. Leufen Medical Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Leufen Medical Main Business
Table 128. Leufen Medical Latest Developments
Table 129. Micro-Tech Endoscopy Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 130. Micro-Tech Endoscopy Covered Esophageal Stent Product Portfolios and Specifications
Table 131. Micro-Tech Endoscopy Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Micro-Tech Endoscopy Main Business
Table 133. Micro-Tech Endoscopy Latest Developments
Table 134. Anrei medical (hz) Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 135. Anrei medical (hz) Covered Esophageal Stent Product Portfolios and Specifications
Table 136. Anrei medical (hz) Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Anrei medical (hz) Main Business
Table 138. Anrei medical (hz) Latest Developments
Table 139. Mitra Industries Private Limited Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 140. Mitra Industries Private Limited Covered Esophageal Stent Product Portfolios and Specifications
Table 141. Mitra Industries Private Limited Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Mitra Industries Private Limited Main Business
Table 143. Mitra Industries Private Limited Latest Developments
Table 144. Sewoon Medical Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 145. Sewoon Medical Covered Esophageal Stent Product Portfolios and Specifications
Table 146. Sewoon Medical Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Sewoon Medical Main Business
Table 148. Sewoon Medical Latest Developments
Table 149. INVAMED Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 150. INVAMED Covered Esophageal Stent Product Portfolios and Specifications
Table 151. INVAMED Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. INVAMED Main Business
Table 153. INVAMED Latest Developments
Table 154. Jiangsu Vedkang Medical Science and Technology Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 155. Jiangsu Vedkang Medical Science and Technology Covered Esophageal Stent Product Portfolios and Specifications
Table 156. Jiangsu Vedkang Medical Science and Technology Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Jiangsu Vedkang Medical Science and Technology Main Business
Table 158. Jiangsu Vedkang Medical Science and Technology Latest Developments
Table 159. Changzhou Zhiye Medical Instrument Research Institute Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 160. Changzhou Zhiye Medical Instrument Research Institute Covered Esophageal Stent Product Portfolios and Specifications
Table 161. Changzhou Zhiye Medical Instrument Research Institute Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Changzhou Zhiye Medical Instrument Research Institute Main Business
Table 163. Changzhou Zhiye Medical Instrument Research Institute Latest Developments
Table 164. AndraTec Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 165. AndraTec Covered Esophageal Stent Product Portfolios and Specifications
Table 166. AndraTec Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. AndraTec Main Business
Table 168. AndraTec Latest Developments
Table 1. Covered Esophageal Stent Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Covered Esophageal Stent Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fully Covered Esophageal Stent
Table 4. Major Players of Partially Covered Esophageal Stent
Table 5. Global Covered Esophageal Stent Sales by Type (2021-2026) & (K Units)
Table 6. Global Covered Esophageal Stent Sales Market Share by Type (2021-2026)
Table 7. Global Covered Esophageal Stent Revenue by Type (2021-2026) & ($ million)
Table 8. Global Covered Esophageal Stent Revenue Market Share by Type (2021-2026)
Table 9. Global Covered Esophageal Stent Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Double Cup Mouth Cylindrical Mesh
Table 11. Major Players of Cup Mouth Ball Head Cylindrical Mesh
Table 12. Global Covered Esophageal Stent Sales by External Structure (2021-2026) & (K Units)
Table 13. Global Covered Esophageal Stent Sales Market Share by External Structure (2021-2026)
Table 14. Global Covered Esophageal Stent Revenue by External Structure (2021-2026) & ($ million)
Table 15. Global Covered Esophageal Stent Revenue Market Share by External Structure (2021-2026)
Table 16. Global Covered Esophageal Stent Sale Price by External Structure (2021-2026) & (US$/Unit)
Table 17. Major Players of Diameter 16 mm
Table 18. Major Players of Diameter 18 mm
Table 19. Major Players of Diameter 20 mm
Table 20. Major Players of Diameter 22 mm
Table 21. Major Players of Diameter 25 mm
Table 22. Global Covered Esophageal Stent Sales by Diameter (2021-2026) & (K Units)
Table 23. Global Covered Esophageal Stent Sales Market Share by Diameter (2021-2026)
Table 24. Global Covered Esophageal Stent Revenue by Diameter (2021-2026) & ($ million)
Table 25. Global Covered Esophageal Stent Revenue Market Share by Diameter (2021-2026)
Table 26. Global Covered Esophageal Stent Sale Price by Diameter (2021-2026) & (US$/Unit)
Table 27. Global Covered Esophageal Stent Sale by Application (2021-2026) & (K Units)
Table 28. Global Covered Esophageal Stent Sale Market Share by Application (2021-2026)
Table 29. Global Covered Esophageal Stent Revenue by Application (2021-2026) & ($ million)
Table 30. Global Covered Esophageal Stent Revenue Market Share by Application (2021-2026)
Table 31. Global Covered Esophageal Stent Sale Price by Application (2021-2026) & (US$/Unit)
Table 32. Global Covered Esophageal Stent Sales by Company (2021-2026) & (K Units)
Table 33. Global Covered Esophageal Stent Sales Market Share by Company (2021-2026)
Table 34. Global Covered Esophageal Stent Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Covered Esophageal Stent Revenue Market Share by Company (2021-2026)
Table 36. Global Covered Esophageal Stent Sale Price by Company (2021-2026) & (US$/Unit)
Table 37. Key Manufacturers Covered Esophageal Stent Producing Area Distribution and Sales Area
Table 38. Players Covered Esophageal Stent Products Offered
Table 39. Covered Esophageal Stent Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Covered Esophageal Stent Sales by Geographic Region (2021-2026) & (K Units)
Table 43. Global Covered Esophageal Stent Sales Market Share Geographic Region (2021-2026)
Table 44. Global Covered Esophageal Stent Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Covered Esophageal Stent Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Covered Esophageal Stent Sales by Country/Region (2021-2026) & (K Units)
Table 47. Global Covered Esophageal Stent Sales Market Share by Country/Region (2021-2026)
Table 48. Global Covered Esophageal Stent Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Covered Esophageal Stent Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Covered Esophageal Stent Sales by Country (2021-2026) & (K Units)
Table 51. Americas Covered Esophageal Stent Sales Market Share by Country (2021-2026)
Table 52. Americas Covered Esophageal Stent Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Covered Esophageal Stent Sales by Type (2021-2026) & (K Units)
Table 54. Americas Covered Esophageal Stent Sales by Application (2021-2026) & (K Units)
Table 55. APAC Covered Esophageal Stent Sales by Region (2021-2026) & (K Units)
Table 56. APAC Covered Esophageal Stent Sales Market Share by Region (2021-2026)
Table 57. APAC Covered Esophageal Stent Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Covered Esophageal Stent Sales by Type (2021-2026) & (K Units)
Table 59. APAC Covered Esophageal Stent Sales by Application (2021-2026) & (K Units)
Table 60. Europe Covered Esophageal Stent Sales by Country (2021-2026) & (K Units)
Table 61. Europe Covered Esophageal Stent Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Covered Esophageal Stent Sales by Type (2021-2026) & (K Units)
Table 63. Europe Covered Esophageal Stent Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Covered Esophageal Stent Sales by Country (2021-2026) & (K Units)
Table 65. Middle East & Africa Covered Esophageal Stent Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Covered Esophageal Stent Sales by Type (2021-2026) & (K Units)
Table 67. Middle East & Africa Covered Esophageal Stent Sales by Application (2021-2026) & (K Units)
Table 68. Key Market Drivers & Growth Opportunities of Covered Esophageal Stent
Table 69. Key Market Challenges & Risks of Covered Esophageal Stent
Table 70. Key Industry Trends of Covered Esophageal Stent
Table 71. Covered Esophageal Stent Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Covered Esophageal Stent Distributors List
Table 74. Covered Esophageal Stent Customer List
Table 75. Global Covered Esophageal Stent Sales Forecast by Region (2027-2032) & (K Units)
Table 76. Global Covered Esophageal Stent Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Covered Esophageal Stent Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Americas Covered Esophageal Stent Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Covered Esophageal Stent Sales Forecast by Region (2027-2032) & (K Units)
Table 80. APAC Covered Esophageal Stent Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Covered Esophageal Stent Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Europe Covered Esophageal Stent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Covered Esophageal Stent Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Middle East & Africa Covered Esophageal Stent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Covered Esophageal Stent Sales Forecast by Type (2027-2032) & (K Units)
Table 86. Global Covered Esophageal Stent Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Covered Esophageal Stent Sales Forecast by Application (2027-2032) & (K Units)
Table 88. Global Covered Esophageal Stent Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Boston Scientific Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 90. Boston Scientific Covered Esophageal Stent Product Portfolios and Specifications
Table 91. Boston Scientific Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Boston Scientific Main Business
Table 93. Boston Scientific Latest Developments
Table 94. Cook Medical Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 95. Cook Medical Covered Esophageal Stent Product Portfolios and Specifications
Table 96. Cook Medical Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Cook Medical Main Business
Table 98. Cook Medical Latest Developments
Table 99. M.I.Tech Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 100. M.I.Tech Covered Esophageal Stent Product Portfolios and Specifications
Table 101. M.I.Tech Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. M.I.Tech Main Business
Table 103. M.I.Tech Latest Developments
Table 104. Merit Medical Systems Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 105. Merit Medical Systems Covered Esophageal Stent Product Portfolios and Specifications
Table 106. Merit Medical Systems Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Merit Medical Systems Main Business
Table 108. Merit Medical Systems Latest Developments
Table 109. Olympus Corporation Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 110. Olympus Corporation Covered Esophageal Stent Product Portfolios and Specifications
Table 111. Olympus Corporation Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Olympus Corporation Main Business
Table 113. Olympus Corporation Latest Developments
Table 114. ELLA-CS, s.r.o. Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 115. ELLA-CS, s.r.o. Covered Esophageal Stent Product Portfolios and Specifications
Table 116. ELLA-CS, s.r.o. Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. ELLA-CS, s.r.o. Main Business
Table 118. ELLA-CS, s.r.o. Latest Developments
Table 119. ENDO-FLEX GmbH Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 120. ENDO-FLEX GmbH Covered Esophageal Stent Product Portfolios and Specifications
Table 121. ENDO-FLEX GmbH Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. ENDO-FLEX GmbH Main Business
Table 123. ENDO-FLEX GmbH Latest Developments
Table 124. Leufen Medical Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 125. Leufen Medical Covered Esophageal Stent Product Portfolios and Specifications
Table 126. Leufen Medical Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Leufen Medical Main Business
Table 128. Leufen Medical Latest Developments
Table 129. Micro-Tech Endoscopy Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 130. Micro-Tech Endoscopy Covered Esophageal Stent Product Portfolios and Specifications
Table 131. Micro-Tech Endoscopy Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Micro-Tech Endoscopy Main Business
Table 133. Micro-Tech Endoscopy Latest Developments
Table 134. Anrei medical (hz) Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 135. Anrei medical (hz) Covered Esophageal Stent Product Portfolios and Specifications
Table 136. Anrei medical (hz) Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Anrei medical (hz) Main Business
Table 138. Anrei medical (hz) Latest Developments
Table 139. Mitra Industries Private Limited Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 140. Mitra Industries Private Limited Covered Esophageal Stent Product Portfolios and Specifications
Table 141. Mitra Industries Private Limited Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Mitra Industries Private Limited Main Business
Table 143. Mitra Industries Private Limited Latest Developments
Table 144. Sewoon Medical Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 145. Sewoon Medical Covered Esophageal Stent Product Portfolios and Specifications
Table 146. Sewoon Medical Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Sewoon Medical Main Business
Table 148. Sewoon Medical Latest Developments
Table 149. INVAMED Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 150. INVAMED Covered Esophageal Stent Product Portfolios and Specifications
Table 151. INVAMED Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. INVAMED Main Business
Table 153. INVAMED Latest Developments
Table 154. Jiangsu Vedkang Medical Science and Technology Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 155. Jiangsu Vedkang Medical Science and Technology Covered Esophageal Stent Product Portfolios and Specifications
Table 156. Jiangsu Vedkang Medical Science and Technology Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Jiangsu Vedkang Medical Science and Technology Main Business
Table 158. Jiangsu Vedkang Medical Science and Technology Latest Developments
Table 159. Changzhou Zhiye Medical Instrument Research Institute Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 160. Changzhou Zhiye Medical Instrument Research Institute Covered Esophageal Stent Product Portfolios and Specifications
Table 161. Changzhou Zhiye Medical Instrument Research Institute Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Changzhou Zhiye Medical Instrument Research Institute Main Business
Table 163. Changzhou Zhiye Medical Instrument Research Institute Latest Developments
Table 164. AndraTec Basic Information, Covered Esophageal Stent Manufacturing Base, Sales Area and Its Competitors
Table 165. AndraTec Covered Esophageal Stent Product Portfolios and Specifications
Table 166. AndraTec Covered Esophageal Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. AndraTec Main Business
Table 168. AndraTec Latest Developments
LIST OF FIGURES
Figure 1. Picture of Covered Esophageal Stent
Figure 2. Covered Esophageal Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Covered Esophageal Stent Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Covered Esophageal Stent Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Covered Esophageal Stent Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Covered Esophageal Stent Sales Market Share by Country/Region (2025)
Figure 10. Covered Esophageal Stent Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Fully Covered Esophageal Stent
Figure 12. Product Picture of Partially Covered Esophageal Stent
Figure 13. Global Covered Esophageal Stent Sales Market Share by Type in 2026
Figure 14. Global Covered Esophageal Stent Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Double Cup Mouth Cylindrical Mesh
Figure 16. Product Picture of Cup Mouth Ball Head Cylindrical Mesh
Figure 17. Global Covered Esophageal Stent Sales Market Share by External Structure in 2026
Figure 18. Global Covered Esophageal Stent Revenue Market Share by External Structure (2021-2026)
Figure 19. Product Picture of Diameter 16 mm
Figure 20. Product Picture of Diameter 18 mm
Figure 21. Product Picture of Diameter 20 mm
Figure 22. Product Picture of Diameter 22 mm
Figure 23. Product Picture of Diameter 25 mm
Figure 24. Global Covered Esophageal Stent Sales Market Share by Diameter in 2026
Figure 25. Global Covered Esophageal Stent Revenue Market Share by Diameter (2021-2026)
Figure 26. Covered Esophageal Stent Consumed in Malignant Esophageal Stricture
Figure 27. Global Covered Esophageal Stent Market: Malignant Esophageal Stricture (2021-2026) & (K Units)
Figure 28. Covered Esophageal Stent Consumed in Benign Esophageal Stricture
Figure 29. Global Covered Esophageal Stent Market: Benign Esophageal Stricture (2021-2026) & (K Units)
Figure 30. Covered Esophageal Stent Consumed in Esophageal Fistula and Perforation
Figure 31. Global Covered Esophageal Stent Market: Esophageal Fistula and Perforation (2021-2026) & (K Units)
Figure 32. Covered Esophageal Stent Consumed in Other
Figure 33. Global Covered Esophageal Stent Market: Other (2021-2026) & (K Units)
Figure 34. Global Covered Esophageal Stent Sale Market Share by Application (2025)
Figure 35. Global Covered Esophageal Stent Revenue Market Share by Application in 2025
Figure 36. Covered Esophageal Stent Sales by Company in 2025 (K Units)
Figure 37. Global Covered Esophageal Stent Sales Market Share by Company in 2025
Figure 38. Covered Esophageal Stent Revenue by Company in 2025 ($ millions)
Figure 39. Global Covered Esophageal Stent Revenue Market Share by Company in 2025
Figure 40. Global Covered Esophageal Stent Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Covered Esophageal Stent Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Covered Esophageal Stent Sales 2021-2026 (K Units)
Figure 43. Americas Covered Esophageal Stent Revenue 2021-2026 ($ millions)
Figure 44. APAC Covered Esophageal Stent Sales 2021-2026 (K Units)
Figure 45. APAC Covered Esophageal Stent Revenue 2021-2026 ($ millions)
Figure 46. Europe Covered Esophageal Stent Sales 2021-2026 (K Units)
Figure 47. Europe Covered Esophageal Stent Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Covered Esophageal Stent Sales 2021-2026 (K Units)
Figure 49. Middle East & Africa Covered Esophageal Stent Revenue 2021-2026 ($ millions)
Figure 50. Americas Covered Esophageal Stent Sales Market Share by Country in 2025
Figure 51. Americas Covered Esophageal Stent Revenue Market Share by Country (2021-2026)
Figure 52. Americas Covered Esophageal Stent Sales Market Share by Type (2021-2026)
Figure 53. Americas Covered Esophageal Stent Sales Market Share by Application (2021-2026)
Figure 54. United States Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Covered Esophageal Stent Sales Market Share by Region in 2025
Figure 59. APAC Covered Esophageal Stent Revenue Market Share by Region (2021-2026)
Figure 60. APAC Covered Esophageal Stent Sales Market Share by Type (2021-2026)
Figure 61. APAC Covered Esophageal Stent Sales Market Share by Application (2021-2026)
Figure 62. China Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 66. India Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Covered Esophageal Stent Sales Market Share by Country in 2025
Figure 70. Europe Covered Esophageal Stent Revenue Market Share by Country (2021-2026)
Figure 71. Europe Covered Esophageal Stent Sales Market Share by Type (2021-2026)
Figure 72. Europe Covered Esophageal Stent Sales Market Share by Application (2021-2026)
Figure 73. Germany Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 74. France Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Covered Esophageal Stent Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Covered Esophageal Stent Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Covered Esophageal Stent Sales Market Share by Application (2021-2026)
Figure 81. Egypt Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Covered Esophageal Stent in 2026
Figure 87. Manufacturing Process Analysis of Covered Esophageal Stent
Figure 88. Industry Chain Structure of Covered Esophageal Stent
Figure 89. Channels of Distribution
Figure 90. Global Covered Esophageal Stent Sales Market Forecast by Region (2027-2032)
Figure 91. Global Covered Esophageal Stent Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Covered Esophageal Stent Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Covered Esophageal Stent Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Covered Esophageal Stent Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Covered Esophageal Stent Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Covered Esophageal Stent
Figure 2. Covered Esophageal Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Covered Esophageal Stent Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Covered Esophageal Stent Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Covered Esophageal Stent Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Covered Esophageal Stent Sales Market Share by Country/Region (2025)
Figure 10. Covered Esophageal Stent Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Fully Covered Esophageal Stent
Figure 12. Product Picture of Partially Covered Esophageal Stent
Figure 13. Global Covered Esophageal Stent Sales Market Share by Type in 2026
Figure 14. Global Covered Esophageal Stent Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Double Cup Mouth Cylindrical Mesh
Figure 16. Product Picture of Cup Mouth Ball Head Cylindrical Mesh
Figure 17. Global Covered Esophageal Stent Sales Market Share by External Structure in 2026
Figure 18. Global Covered Esophageal Stent Revenue Market Share by External Structure (2021-2026)
Figure 19. Product Picture of Diameter 16 mm
Figure 20. Product Picture of Diameter 18 mm
Figure 21. Product Picture of Diameter 20 mm
Figure 22. Product Picture of Diameter 22 mm
Figure 23. Product Picture of Diameter 25 mm
Figure 24. Global Covered Esophageal Stent Sales Market Share by Diameter in 2026
Figure 25. Global Covered Esophageal Stent Revenue Market Share by Diameter (2021-2026)
Figure 26. Covered Esophageal Stent Consumed in Malignant Esophageal Stricture
Figure 27. Global Covered Esophageal Stent Market: Malignant Esophageal Stricture (2021-2026) & (K Units)
Figure 28. Covered Esophageal Stent Consumed in Benign Esophageal Stricture
Figure 29. Global Covered Esophageal Stent Market: Benign Esophageal Stricture (2021-2026) & (K Units)
Figure 30. Covered Esophageal Stent Consumed in Esophageal Fistula and Perforation
Figure 31. Global Covered Esophageal Stent Market: Esophageal Fistula and Perforation (2021-2026) & (K Units)
Figure 32. Covered Esophageal Stent Consumed in Other
Figure 33. Global Covered Esophageal Stent Market: Other (2021-2026) & (K Units)
Figure 34. Global Covered Esophageal Stent Sale Market Share by Application (2025)
Figure 35. Global Covered Esophageal Stent Revenue Market Share by Application in 2025
Figure 36. Covered Esophageal Stent Sales by Company in 2025 (K Units)
Figure 37. Global Covered Esophageal Stent Sales Market Share by Company in 2025
Figure 38. Covered Esophageal Stent Revenue by Company in 2025 ($ millions)
Figure 39. Global Covered Esophageal Stent Revenue Market Share by Company in 2025
Figure 40. Global Covered Esophageal Stent Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Covered Esophageal Stent Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Covered Esophageal Stent Sales 2021-2026 (K Units)
Figure 43. Americas Covered Esophageal Stent Revenue 2021-2026 ($ millions)
Figure 44. APAC Covered Esophageal Stent Sales 2021-2026 (K Units)
Figure 45. APAC Covered Esophageal Stent Revenue 2021-2026 ($ millions)
Figure 46. Europe Covered Esophageal Stent Sales 2021-2026 (K Units)
Figure 47. Europe Covered Esophageal Stent Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Covered Esophageal Stent Sales 2021-2026 (K Units)
Figure 49. Middle East & Africa Covered Esophageal Stent Revenue 2021-2026 ($ millions)
Figure 50. Americas Covered Esophageal Stent Sales Market Share by Country in 2025
Figure 51. Americas Covered Esophageal Stent Revenue Market Share by Country (2021-2026)
Figure 52. Americas Covered Esophageal Stent Sales Market Share by Type (2021-2026)
Figure 53. Americas Covered Esophageal Stent Sales Market Share by Application (2021-2026)
Figure 54. United States Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Covered Esophageal Stent Sales Market Share by Region in 2025
Figure 59. APAC Covered Esophageal Stent Revenue Market Share by Region (2021-2026)
Figure 60. APAC Covered Esophageal Stent Sales Market Share by Type (2021-2026)
Figure 61. APAC Covered Esophageal Stent Sales Market Share by Application (2021-2026)
Figure 62. China Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 66. India Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Covered Esophageal Stent Sales Market Share by Country in 2025
Figure 70. Europe Covered Esophageal Stent Revenue Market Share by Country (2021-2026)
Figure 71. Europe Covered Esophageal Stent Sales Market Share by Type (2021-2026)
Figure 72. Europe Covered Esophageal Stent Sales Market Share by Application (2021-2026)
Figure 73. Germany Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 74. France Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Covered Esophageal Stent Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Covered Esophageal Stent Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Covered Esophageal Stent Sales Market Share by Application (2021-2026)
Figure 81. Egypt Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Covered Esophageal Stent Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Covered Esophageal Stent in 2026
Figure 87. Manufacturing Process Analysis of Covered Esophageal Stent
Figure 88. Industry Chain Structure of Covered Esophageal Stent
Figure 89. Channels of Distribution
Figure 90. Global Covered Esophageal Stent Sales Market Forecast by Region (2027-2032)
Figure 91. Global Covered Esophageal Stent Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Covered Esophageal Stent Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Covered Esophageal Stent Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Covered Esophageal Stent Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Covered Esophageal Stent Revenue Market Share Forecast by Application (2027-2032)
